FibroPlant LNG IUS | The Contraceptive Pipeline Database

Product Overview

Alternative Name: Fibroplant LNG14 (also LNG 20)

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: A frameless LNG IUS releasing 14 mcg, or 20 mcg, of LNG/day for contraception. Anchoring technology affixes the device to the endometrium.

Updated date: May 30, 2018

Vertical Tabs

Product Details

Active Pharmaceutical Ingredient (API): levonorgestrel

Potential Multi-Purpose Technology (MPT): No

Duration: 3-5 years

Dose: 14 or 20 µg per day

Partner: Contrel Research, Belgium

Status

Project Phase: Post-development

Project Stage: Regulatory

Programmatic Considerations

Additional Information

Additional Information:
Andrade A, Wildemeersch D. (2008) Menstrual blood loss in women using the frameless FibroPlant LNG-IUS. Contraception. 79(2):134-8.

Wildemeersch D. (2007) New frameless and framed intrauterine devices and systems: An overview. Contraception. 75(6 Suppl):S82-92.

Download Product Report